The Health Resources and Services Administration (HRSA) has finalized modifications to the Administrative Dispute Resolution (ADR) process associated with the federal 340B drug discount program that are aimed at ensuring the process is less “trial-like” and more accessible to all stakeholders involved. It will be run by a panel of various subject matter experts and offers opportunities for decisions to be appealed, according to a final rule on the matter posted Thursday (April 18). Hospitals are pleased with the changes,...